| P50 | author | Peter Meldgaard | Q43313514 |
| | Boe Sandahl Sorensen | Q56797606 |
| | Ebba Nexø | Q62079837 |
| | Ashfaque A Memon | Q63979736 |
| P2093 | author name string | L Fokdal | |
| | T Thykjaer | |
| P2860 | cites work | Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients | Q24645597 |
| | Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling | Q24794988 |
| | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| | Untangling the ErbB signalling network | Q27860884 |
| | Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer | Q28248266 |
| | Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions | Q28609149 |
| | The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells | Q28678816 |
| | The ErbB signaling network: receptor heterodimerization in development and cancer | Q29617919 |
| | Bivalence of EGF-like ligands drives the ErbB signaling network | Q33887274 |
| | Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. | Q33968565 |
| | A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients | Q34086975 |
| | Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 |
| | Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity | Q35684026 |
| | Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma | Q36696088 |
| | Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? | Q38455324 |
| | Prognostic value of amplification of c-erb-B2 in bladder carcinoma | Q38479838 |
| | Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. | Q40450413 |
| | Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas | Q40554806 |
| | Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma | Q42466578 |
| | Expression of the epidermal growth factor receptor family in normal and malignant urothelium | Q42478245 |
| | Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. | Q42834135 |
| | c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival | Q43926200 |
| | Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer | Q44503047 |
| | HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study | Q45050365 |
| | Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast | Q46402523 |
| | HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors | Q47290140 |
| | Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. | Q47771329 |
| | Comparative analysis of the EGF-receptor family in pancreatic cancer: expression of HER-4 correlates with a favourable tumor stage | Q47991131 |
| | EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. | Q53810400 |
| | c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer | Q64019053 |
| | C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value | Q71566796 |
| | Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors | Q71842136 |
| | Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years | Q72588330 |
| | Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer | Q73174777 |
| | Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer | Q73223665 |
| | Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors | Q74321060 |
| | Potential molecular marker for detecting transitional cell carcinoma | Q74419973 |
| | Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas | Q77747973 |
| | HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications | Q78516471 |
| | Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue | Q81612144 |
| | Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based | Q81742060 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bladder cancer | Q504775 |
| P304 | page(s) | 1703-1709 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients | |
| P478 | volume | 94 | |